Switch to:
More From Other Websites
Sanofi & Regeneron Enter Immuno-Oncology Collaboration - Analyst Blog Jul 29 2015
Sanofi-Regeneron: Third Time's the Charm? Jul 29 2015
Genzyme Launches Fifth Annual Patient Advocacy Leadership (PAL) Awards Program Jul 29 2015
Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint Jul 29 2015
2:47 am Sanofi-Aventis and Zealand reports that the LixiLan GLP-1/basal insulin Phase 3 trial met... Jul 29 2015
Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint Jul 29 2015
5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen Jul 28 2015
Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal Jul 28 2015
Regeneron Shares Rising After Sanofi Collaboration Revealed: Good News For Shareholders? Jul 28 2015
Regeneron's George Yancopoulos Becomes Pharma's First Billionaire R&D Chief Jul 28 2015
Struggling Sanofi Sends Cancer SOS to Regeneron and Another Vanity Biotech IPO Launches Jul 28 2015
Sanofi links with Regeneron in $2.2 bln cancer drug push Jul 28 2015
Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration Jul 28 2015
Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration Jul 28 2015
Sanofi Joins Regeneron in $2.2 Billion Pact for Cancer Therapies Jul 28 2015
Sanofi paying up to $300M for rare thyroid cancer drug Jul 27 2015
Sanofi paying up to $300M for rare thyroid cancer drug Jul 27 2015
Why Regeneron's Approval is Bad News For Esperion Therapeutics Jul 27 2015
New England Journal of Medicine Publishes New Analyses Confirming that Sanofi Pasteur's Vaccine... Jul 27 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK